Company intelligence / Profile preview

TAP Pharmaceutical Products

Lake Forest, Illinois, United States

Ownership: Private
Employees: ~5000
Development stage: Other

Overview

TAP was highly successful with two key commercial products: lansoprazole (Prevacid) for acid-related diseases and leuprorelin (Lupron) for prostate cancer and other hormone-dependent conditions. The company also developed and marketed antibiotics and explored additional pipeline drugs, though some were withdrawn or discontinued.[1][3][5][7]

Therapeutic areas: OncologyInfectious DiseasesWomen's HealthNephrologyEndocrinologyGastroenterology
Modalities: Small moleculePeptides
Industry: Pharma

Drug pipeline

2 assets

asoprisnil

1 more asset in the full pipeline.

Request access →

Partnerships

Abbott LaboratoriesTakeda Pharmaceutical Company

Beyond the preview

Go deeper on TAP Pharmaceutical Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TAP Pharmaceutical Products.

Explore the full profile